ATS Opposes FDA Decision to Approve Over-the-Counter Epinephrine for the Treatment of Asthma
American Thoracic Society (ATS)The American Thoracic Society is gravely concerned and disappointed in the FDA’s decision to approve over the counter epinephrine (Primatene Mist HFA) for consumer use to treat asthma. The ATS is a medical professional society dedicated to the prevention, detection, treatment and research of pulmonary disease, critical care illness and sleep disordered breathing. Our members are experts in the diagnosis and management of asthma and have published several clinical practice guidelines for the treatment of asthma. It is with our extensive clinical expertise in the treatment of asthma and our concern for the patients that we oppose the FDA’s decision.